nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2C9—brain cancer	0.487	1	CbGaD
Doxepin—CYP2D6—Lomustine—brain cancer	0.0429	0.207	CbGbCtD
Doxepin—CYP1A2—Carmustine—brain cancer	0.0425	0.205	CbGbCtD
Doxepin—CYP2D6—Hydroxyurea—brain cancer	0.0325	0.157	CbGbCtD
Doxepin—CYP3A4—Temozolomide—brain cancer	0.0321	0.155	CbGbCtD
Doxepin—CYP3A4—Lomustine—brain cancer	0.0273	0.132	CbGbCtD
Doxepin—CYP1A2—Etoposide—brain cancer	0.0126	0.0607	CbGbCtD
Doxepin—ABCB1—Etoposide—brain cancer	0.011	0.0531	CbGbCtD
Doxepin—HTR2C—choroid plexus—brain cancer	0.00791	0.0799	CbGeAlD
Doxepin—CYP3A4—Etoposide—brain cancer	0.0066	0.0318	CbGbCtD
Doxepin—HTR2A—choroid plexus—brain cancer	0.00397	0.0401	CbGeAlD
Doxepin—HRH1—nose—brain cancer	0.00306	0.0309	CbGeAlD
Doxepin—HTR6—ganglion—brain cancer	0.0025	0.0252	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—brain cancer	0.00232	0.0234	CbGeAlD
Doxepin—HTR2A—trigeminal nerve—brain cancer	0.00201	0.0203	CbGeAlD
Doxepin—HTR2A—cerebellar cortex—brain cancer	0.002	0.0202	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—brain cancer	0.00195	0.0197	CbGeAlD
Doxepin—HTR2A—vein—brain cancer	0.00181	0.0183	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—brain cancer	0.00176	0.0178	CbGeAlD
Doxepin—HTR2C—ganglion—brain cancer	0.00144	0.0146	CbGeAlD
Doxepin—HTR2A—cranial nerve—brain cancer	0.00143	0.0144	CbGeAlD
Doxepin—HTR2A—pons—brain cancer	0.00141	0.0143	CbGeAlD
Doxepin—SLC6A4—ganglion—brain cancer	0.00137	0.0138	CbGeAlD
Doxepin—HTR1A—ganglion—brain cancer	0.00121	0.0123	CbGeAlD
Doxepin—SLC6A2—ganglion—brain cancer	0.0012	0.0122	CbGeAlD
Doxepin—HTR2A—telencephalic ventricle—brain cancer	0.00116	0.0117	CbGeAlD
Doxepin—DRD2—ganglion—brain cancer	0.0011	0.0111	CbGeAlD
Doxepin—SLC6A4—hindbrain—brain cancer	0.00104	0.0105	CbGeAlD
Doxepin—HTR2A—pineal body—brain cancer	0.00101	0.0102	CbGeAlD
Doxepin—HTR6—telencephalon—brain cancer	0.000963	0.00973	CbGeAlD
Doxepin—HTR1A—hindbrain—brain cancer	0.000921	0.0093	CbGeAlD
Doxepin—ADRA1A—hindbrain—brain cancer	0.000849	0.00858	CbGeAlD
Doxepin—DRD2—hindbrain—brain cancer	0.000832	0.00841	CbGeAlD
Doxepin—ADRA1D—telencephalon—brain cancer	0.000752	0.0076	CbGeAlD
Doxepin—HTR2A—ganglion—brain cancer	0.000724	0.00731	CbGeAlD
Doxepin—CHRM4—head—brain cancer	0.00067	0.00677	CbGeAlD
Doxepin—HTR2C—brainstem—brain cancer	0.000627	0.00634	CbGeAlD
Doxepin—HTR2A—endothelium—brain cancer	0.000624	0.0063	CbGeAlD
Doxepin—CHRM4—central nervous system—brain cancer	0.000612	0.00618	CbGeAlD
Doxepin—HTR6—head—brain cancer	0.0006	0.00606	CbGeAlD
Doxepin—SLC6A4—brainstem—brain cancer	0.000595	0.00601	CbGeAlD
Doxepin—CHRM2—telencephalon—brain cancer	0.000577	0.00583	CbGeAlD
Doxepin—HTR2A—blood vessel—brain cancer	0.000575	0.00581	CbGeAlD
Doxepin—HTR2C—telencephalon—brain cancer	0.000557	0.00562	CbGeAlD
Doxepin—HRH2—endocrine gland—brain cancer	0.000555	0.00561	CbGeAlD
Doxepin—HTR2A—hindbrain—brain cancer	0.000549	0.00554	CbGeAlD
Doxepin—HRH2—head—brain cancer	0.000548	0.00554	CbGeAlD
Doxepin—HTR6—central nervous system—brain cancer	0.000547	0.00553	CbGeAlD
Doxepin—HTR1A—brainstem—brain cancer	0.000528	0.00533	CbGeAlD
Doxepin—SLC6A4—telencephalon—brain cancer	0.000528	0.00533	CbGeAlD
Doxepin—CHRM1—telencephalon—brain cancer	0.000526	0.00531	CbGeAlD
Doxepin—CHRM5—head—brain cancer	0.000524	0.00529	CbGeAlD
Doxepin—SLC6A2—brainstem—brain cancer	0.000523	0.00529	CbGeAlD
Doxepin—HTR2B—telencephalon—brain cancer	0.000523	0.00528	CbGeAlD
Doxepin—HRH2—central nervous system—brain cancer	0.000501	0.00506	CbGeAlD
Doxepin—CYP2D6—hindbrain—brain cancer	0.0005	0.00505	CbGeAlD
Doxepin—ADRA1A—brainstem—brain cancer	0.000487	0.00492	CbGeAlD
Doxepin—CHRM4—brain—brain cancer	0.000486	0.00491	CbGeAlD
Doxepin—ADRA1B—head—brain cancer	0.000479	0.00484	CbGeAlD
Doxepin—CHRM5—central nervous system—brain cancer	0.000478	0.00483	CbGeAlD
Doxepin—DRD2—brainstem—brain cancer	0.000477	0.00482	CbGeAlD
Doxepin—ADRA1D—endocrine gland—brain cancer	0.000474	0.00479	CbGeAlD
Doxepin—CHRM3—telencephalon—brain cancer	0.00047	0.00475	CbGeAlD
Doxepin—HTR1A—telencephalon—brain cancer	0.000468	0.00473	CbGeAlD
Doxepin—ADRA1D—head—brain cancer	0.000468	0.00473	CbGeAlD
Doxepin—SLC6A2—telencephalon—brain cancer	0.000465	0.00469	CbGeAlD
Doxepin—HTR2C—medulla oblongata—brain cancer	0.000437	0.00442	CbGeAlD
Doxepin—ADRA1B—central nervous system—brain cancer	0.000437	0.00441	CbGeAlD
Doxepin—HTR6—brain—brain cancer	0.000435	0.00439	CbGeAlD
Doxepin—ORM1—spinal cord—brain cancer	0.000434	0.00438	CbGeAlD
Doxepin—ADRA1A—telencephalon—brain cancer	0.000432	0.00436	CbGeAlD
Doxepin—ADRA1D—central nervous system—brain cancer	0.000427	0.00432	CbGeAlD
Doxepin—DRD2—telencephalon—brain cancer	0.000423	0.00428	CbGeAlD
Doxepin—KCNH2—telencephalon—brain cancer	0.000417	0.00421	CbGeAlD
Doxepin—ADRA2C—telencephalon—brain cancer	0.000411	0.00416	CbGeAlD
Doxepin—HTR2C—midbrain—brain cancer	0.0004	0.00404	CbGeAlD
Doxepin—HRH2—brain—brain cancer	0.000397	0.00401	CbGeAlD
Doxepin—ORM1—endocrine gland—brain cancer	0.000391	0.00395	CbGeAlD
Doxepin—HTR2C—spinal cord—brain cancer	0.00039	0.00394	CbGeAlD
Doxepin—SLC6A2—gonad—brain cancer	0.000388	0.00392	CbGeAlD
Doxepin—CHRM5—brain—brain cancer	0.00038	0.00383	CbGeAlD
Doxepin—SLC6A4—midbrain—brain cancer	0.000379	0.00383	CbGeAlD
Doxepin—ABCB1—blood vessel—brain cancer	0.000377	0.00381	CbGeAlD
Doxepin—SLC6A4—spinal cord—brain cancer	0.00037	0.00373	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—brain cancer	0.000365	0.00369	CbGeAlD
Doxepin—CHRM2—endocrine gland—brain cancer	0.000364	0.00368	CbGeAlD
Doxepin—CHRM2—head—brain cancer	0.00036	0.00363	CbGeAlD
Doxepin—ORM1—central nervous system—brain cancer	0.000352	0.00356	CbGeAlD
Doxepin—ADRA1B—brain—brain cancer	0.000347	0.0035	CbGeAlD
Doxepin—HTR2C—head—brain cancer	0.000347	0.0035	CbGeAlD
Doxepin—DRD2—pituitary gland—brain cancer	0.000345	0.00348	CbGeAlD
Doxepin—KCNH2—pituitary gland—brain cancer	0.00034	0.00343	CbGeAlD
Doxepin—ADRA1D—brain—brain cancer	0.000339	0.00343	CbGeAlD
Doxepin—HTR1A—midbrain—brain cancer	0.000336	0.0034	CbGeAlD
Doxepin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000335	0.00242	CcSEcCtD
Doxepin—ADRA2C—pituitary gland—brain cancer	0.000335	0.00338	CbGeAlD
Doxepin—HRH1—telencephalon—brain cancer	0.000334	0.00338	CbGeAlD
Doxepin—Insomnia—Procarbazine—brain cancer	0.000333	0.0024	CcSEcCtD
Doxepin—SLC6A4—endocrine gland—brain cancer	0.000333	0.00336	CbGeAlD
Doxepin—CHRM1—endocrine gland—brain cancer	0.000332	0.00335	CbGeAlD
Doxepin—Paraesthesia—Procarbazine—brain cancer	0.000331	0.00239	CcSEcCtD
Doxepin—Hepatobiliary disease—Temozolomide—brain cancer	0.00033	0.00238	CcSEcCtD
Doxepin—SLC6A4—head—brain cancer	0.000329	0.00332	CbGeAlD
Doxepin—ADRA2A—telencephalon—brain cancer	0.000328	0.00332	CbGeAlD
Doxepin—HTR1A—spinal cord—brain cancer	0.000328	0.00332	CbGeAlD
Doxepin—CHRM2—central nervous system—brain cancer	0.000328	0.00332	CbGeAlD
Doxepin—KCNH2—medulla oblongata—brain cancer	0.000328	0.00331	CbGeAlD
Doxepin—Sinusitis—Temozolomide—brain cancer	0.000327	0.00236	CcSEcCtD
Doxepin—CHRM1—head—brain cancer	0.000327	0.00331	CbGeAlD
Doxepin—Somnolence—Procarbazine—brain cancer	0.000327	0.00236	CcSEcCtD
Doxepin—Cramp muscle—Etoposide—brain cancer	0.000326	0.00236	CcSEcCtD
Doxepin—HTR2B—head—brain cancer	0.000326	0.00329	CbGeAlD
Doxepin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000324	0.00234	CcSEcCtD
Doxepin—ADRA2C—medulla oblongata—brain cancer	0.000323	0.00327	CbGeAlD
Doxepin—Anaemia—Hydroxyurea—brain cancer	0.000323	0.00233	CcSEcCtD
Doxepin—Hallucination—Carmustine—brain cancer	0.000323	0.00233	CcSEcCtD
Doxepin—Hypoaesthesia—Carmustine—brain cancer	0.000323	0.00233	CcSEcCtD
Doxepin—Nortriptyline—CYP2C9—brain cancer	0.000322	0.19	CrCbGaD
Doxepin—Decreased appetite—Procarbazine—brain cancer	0.00032	0.00231	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Etoposide—brain cancer	0.00032	0.00231	CcSEcCtD
Doxepin—Oedema peripheral—Carmustine—brain cancer	0.000319	0.00231	CcSEcCtD
Doxepin—Connective tissue disorder—Carmustine—brain cancer	0.000319	0.0023	CcSEcCtD
Doxepin—Fatigue—Procarbazine—brain cancer	0.000317	0.00229	CcSEcCtD
Doxepin—HTR2C—central nervous system—brain cancer	0.000316	0.0032	CbGeAlD
Doxepin—Malaise—Hydroxyurea—brain cancer	0.000315	0.00227	CcSEcCtD
Doxepin—Constipation—Procarbazine—brain cancer	0.000315	0.00227	CcSEcCtD
Doxepin—Pain—Procarbazine—brain cancer	0.000315	0.00227	CcSEcCtD
Doxepin—HTR2A—brainstem—brain cancer	0.000315	0.00318	CbGeAlD
Doxepin—Hepatitis—Temozolomide—brain cancer	0.000313	0.00226	CcSEcCtD
Doxepin—Leukopenia—Hydroxyurea—brain cancer	0.000312	0.00226	CcSEcCtD
Doxepin—Hypoaesthesia—Temozolomide—brain cancer	0.000312	0.00225	CcSEcCtD
Doxepin—Hallucination—Temozolomide—brain cancer	0.000312	0.00225	CcSEcCtD
Doxepin—Pharyngitis—Temozolomide—brain cancer	0.000311	0.00224	CcSEcCtD
Doxepin—Urinary tract disorder—Temozolomide—brain cancer	0.000309	0.00223	CcSEcCtD
Doxepin—Oedema peripheral—Temozolomide—brain cancer	0.000309	0.00223	CcSEcCtD
Doxepin—Connective tissue disorder—Temozolomide—brain cancer	0.000308	0.00222	CcSEcCtD
Doxepin—Urethral disorder—Temozolomide—brain cancer	0.000307	0.00222	CcSEcCtD
Doxepin—DRD2—midbrain—brain cancer	0.000304	0.00307	CbGeAlD
Doxepin—Feeling abnormal—Procarbazine—brain cancer	0.000303	0.00219	CcSEcCtD
Doxepin—Trimipramine—CYP2C9—brain cancer	0.000303	0.179	CrCbGaD
Doxepin—Eye disorder—Carmustine—brain cancer	0.000303	0.00219	CcSEcCtD
Doxepin—Convulsion—Hydroxyurea—brain cancer	0.000302	0.00218	CcSEcCtD
Doxepin—Gastrointestinal pain—Procarbazine—brain cancer	0.000301	0.00217	CcSEcCtD
Doxepin—Flushing—Carmustine—brain cancer	0.000301	0.00217	CcSEcCtD
Doxepin—SLC6A4—central nervous system—brain cancer	0.0003	0.00303	CbGeAlD
Doxepin—KCNH2—midbrain—brain cancer	0.0003	0.00303	CbGeAlD
Doxepin—CHRM1—central nervous system—brain cancer	0.000299	0.00302	CbGeAlD
Doxepin—Diphenhydramine—CYP2C9—brain cancer	0.000298	0.176	CrCbGaD
Doxepin—Pancytopenia—Etoposide—brain cancer	0.000297	0.00215	CcSEcCtD
Doxepin—HTR2B—central nervous system—brain cancer	0.000297	0.003	CbGeAlD
Doxepin—CHRM3—endocrine gland—brain cancer	0.000297	0.003	CbGeAlD
Doxepin—ADRA2C—midbrain—brain cancer	0.000296	0.00299	CbGeAlD
Doxepin—HTR1A—endocrine gland—brain cancer	0.000295	0.00298	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000295	0.00213	CcSEcCtD
Doxepin—Discomfort—Hydroxyurea—brain cancer	0.000294	0.00212	CcSEcCtD
Doxepin—SLC6A2—endocrine gland—brain cancer	0.000293	0.00296	CbGeAlD
Doxepin—CHRM3—head—brain cancer	0.000293	0.00296	CbGeAlD
Doxepin—Eye disorder—Temozolomide—brain cancer	0.000293	0.00211	CcSEcCtD
Doxepin—Urticaria—Procarbazine—brain cancer	0.000292	0.00211	CcSEcCtD
Doxepin—KCNH2—spinal cord—brain cancer	0.000292	0.00295	CbGeAlD
Doxepin—Tinnitus—Temozolomide—brain cancer	0.000292	0.00211	CcSEcCtD
Doxepin—Promethazine—CYP2C9—brain cancer	0.000292	0.172	CrCbGaD
Doxepin—HTR1A—head—brain cancer	0.000292	0.00295	CbGeAlD
Doxepin—Abdominal pain—Procarbazine—brain cancer	0.000291	0.0021	CcSEcCtD
Doxepin—Body temperature increased—Procarbazine—brain cancer	0.000291	0.0021	CcSEcCtD
Doxepin—Flushing—Temozolomide—brain cancer	0.000291	0.0021	CcSEcCtD
Doxepin—Cardiac disorder—Temozolomide—brain cancer	0.000291	0.0021	CcSEcCtD
Doxepin—Arrhythmia—Carmustine—brain cancer	0.00029	0.00209	CcSEcCtD
Doxepin—SLC6A2—head—brain cancer	0.000289	0.00292	CbGeAlD
Doxepin—ADRA2C—spinal cord—brain cancer	0.000288	0.00291	CbGeAlD
Doxepin—CYP2D6—brainstem—brain cancer	0.000287	0.0029	CbGeAlD
Doxepin—Alopecia—Carmustine—brain cancer	0.000286	0.00207	CcSEcCtD
Doxepin—Oedema—Hydroxyurea—brain cancer	0.000285	0.00206	CcSEcCtD
Doxepin—Angiopathy—Temozolomide—brain cancer	0.000284	0.00205	CcSEcCtD
Doxepin—Mental disorder—Carmustine—brain cancer	0.000284	0.00205	CcSEcCtD
Doxepin—Infection—Hydroxyurea—brain cancer	0.000283	0.00204	CcSEcCtD
Doxepin—Immune system disorder—Temozolomide—brain cancer	0.000283	0.00204	CcSEcCtD
Doxepin—Mediastinal disorder—Temozolomide—brain cancer	0.000282	0.00204	CcSEcCtD
Doxepin—Malnutrition—Carmustine—brain cancer	0.000282	0.00204	CcSEcCtD
Doxepin—Erythema—Carmustine—brain cancer	0.000282	0.00204	CcSEcCtD
Doxepin—Chills—Temozolomide—brain cancer	0.000281	0.00203	CcSEcCtD
Doxepin—Pneumonia—Etoposide—brain cancer	0.000281	0.00203	CcSEcCtD
Doxepin—Nervous system disorder—Hydroxyurea—brain cancer	0.000279	0.00202	CcSEcCtD
Doxepin—Infestation NOS—Etoposide—brain cancer	0.000279	0.00202	CcSEcCtD
Doxepin—Infestation—Etoposide—brain cancer	0.000279	0.00202	CcSEcCtD
Doxepin—HTR2A—telencephalon—brain cancer	0.000279	0.00282	CbGeAlD
Doxepin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000279	0.00201	CcSEcCtD
Doxepin—Alopecia—Temozolomide—brain cancer	0.000277	0.002	CcSEcCtD
Doxepin—Skin disorder—Hydroxyurea—brain cancer	0.000277	0.002	CcSEcCtD
Doxepin—CYP2C19—endocrine gland—brain cancer	0.000276	0.00279	CbGeAlD
Doxepin—Mental disorder—Temozolomide—brain cancer	0.000274	0.00198	CcSEcCtD
Doxepin—ADRA2A—gonad—brain cancer	0.000274	0.00277	CbGeAlD
Doxepin—Neuropathy peripheral—Etoposide—brain cancer	0.000274	0.00198	CcSEcCtD
Doxepin—Back pain—Carmustine—brain cancer	0.000273	0.00197	CcSEcCtD
Doxepin—Malnutrition—Temozolomide—brain cancer	0.000273	0.00197	CcSEcCtD
Doxepin—Erythema—Temozolomide—brain cancer	0.000273	0.00197	CcSEcCtD
Doxepin—ADRA1A—endocrine gland—brain cancer	0.000272	0.00275	CbGeAlD
Doxepin—Stomatitis—Etoposide—brain cancer	0.000272	0.00197	CcSEcCtD
Doxepin—Jaundice—Etoposide—brain cancer	0.000272	0.00197	CcSEcCtD
Doxepin—Anorexia—Hydroxyurea—brain cancer	0.000272	0.00196	CcSEcCtD
Doxepin—Hypersensitivity—Procarbazine—brain cancer	0.000271	0.00196	CcSEcCtD
Doxepin—ADRA1A—head—brain cancer	0.000269	0.00272	CbGeAlD
Doxepin—ADRA2A—pituitary gland—brain cancer	0.000267	0.0027	CbGeAlD
Doxepin—CHRM3—central nervous system—brain cancer	0.000267	0.0027	CbGeAlD
Doxepin—Dysgeusia—Temozolomide—brain cancer	0.000267	0.00193	CcSEcCtD
Doxepin—DRD2—endocrine gland—brain cancer	0.000267	0.0027	CbGeAlD
Doxepin—HTR1A—central nervous system—brain cancer	0.000266	0.00269	CbGeAlD
Doxepin—Vision blurred—Carmustine—brain cancer	0.000266	0.00192	CcSEcCtD
Doxepin—Tremor—Carmustine—brain cancer	0.000264	0.00191	CcSEcCtD
Doxepin—Asthenia—Procarbazine—brain cancer	0.000264	0.00191	CcSEcCtD
Doxepin—Hepatobiliary disease—Etoposide—brain cancer	0.000264	0.00191	CcSEcCtD
Doxepin—SLC6A2—central nervous system—brain cancer	0.000264	0.00267	CbGeAlD
Doxepin—Back pain—Temozolomide—brain cancer	0.000264	0.0019	CcSEcCtD
Doxepin—DRD2—head—brain cancer	0.000264	0.00266	CbGeAlD
Doxepin—KCNH2—endocrine gland—brain cancer	0.000263	0.00266	CbGeAlD
Doxepin—Anaemia—Carmustine—brain cancer	0.000261	0.00188	CcSEcCtD
Doxepin—Agranulocytosis—Etoposide—brain cancer	0.000261	0.00188	CcSEcCtD
Doxepin—CHRM2—brain—brain cancer	0.000261	0.00263	CbGeAlD
Doxepin—Pruritus—Procarbazine—brain cancer	0.00026	0.00188	CcSEcCtD
Doxepin—HTR1A—cerebellum—brain cancer	0.00026	0.00263	CbGeAlD
Doxepin—KCNH2—head—brain cancer	0.00026	0.00262	CbGeAlD
Doxepin—Agitation—Carmustine—brain cancer	0.000259	0.00187	CcSEcCtD
Doxepin—ADRA2A—medulla oblongata—brain cancer	0.000258	0.00261	CbGeAlD
Doxepin—Vision blurred—Temozolomide—brain cancer	0.000257	0.00186	CcSEcCtD
Doxepin—Promazine—CYP2C9—brain cancer	0.000257	0.152	CrCbGaD
Doxepin—ADRA2C—head—brain cancer	0.000256	0.00259	CbGeAlD
Doxepin—Tremor—Temozolomide—brain cancer	0.000256	0.00184	CcSEcCtD
Doxepin—CYP2D6—telencephalon—brain cancer	0.000254	0.00257	CbGeAlD
Doxepin—Dyspnoea—Hydroxyurea—brain cancer	0.000254	0.00183	CcSEcCtD
Doxepin—Somnolence—Hydroxyurea—brain cancer	0.000253	0.00183	CcSEcCtD
Doxepin—Ill-defined disorder—Temozolomide—brain cancer	0.000253	0.00183	CcSEcCtD
Doxepin—Leukopenia—Carmustine—brain cancer	0.000253	0.00182	CcSEcCtD
Doxepin—Anaemia—Temozolomide—brain cancer	0.000252	0.00182	CcSEcCtD
Doxepin—Diarrhoea—Procarbazine—brain cancer	0.000252	0.00182	CcSEcCtD
Doxepin—HTR2C—brain—brain cancer	0.000251	0.00254	CbGeAlD
Doxepin—Dyspepsia—Hydroxyurea—brain cancer	0.000251	0.00181	CcSEcCtD
Doxepin—Agitation—Temozolomide—brain cancer	0.000251	0.00181	CcSEcCtD
Doxepin—Hypoaesthesia—Etoposide—brain cancer	0.000249	0.0018	CcSEcCtD
Doxepin—Decreased appetite—Hydroxyurea—brain cancer	0.000248	0.00179	CcSEcCtD
Doxepin—Urinary tract disorder—Etoposide—brain cancer	0.000248	0.00179	CcSEcCtD
Doxepin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000246	0.00178	CcSEcCtD
Doxepin—Malaise—Temozolomide—brain cancer	0.000246	0.00178	CcSEcCtD
Doxepin—Urethral disorder—Etoposide—brain cancer	0.000246	0.00177	CcSEcCtD
Doxepin—Fatigue—Hydroxyurea—brain cancer	0.000246	0.00177	CcSEcCtD
Doxepin—ADRA1A—central nervous system—brain cancer	0.000245	0.00248	CbGeAlD
Doxepin—Vertigo—Temozolomide—brain cancer	0.000245	0.00177	CcSEcCtD
Doxepin—Convulsion—Carmustine—brain cancer	0.000245	0.00177	CcSEcCtD
Doxepin—Leukopenia—Temozolomide—brain cancer	0.000244	0.00176	CcSEcCtD
Doxepin—Hypertension—Carmustine—brain cancer	0.000244	0.00176	CcSEcCtD
Doxepin—Pain—Hydroxyurea—brain cancer	0.000244	0.00176	CcSEcCtD
Doxepin—Constipation—Hydroxyurea—brain cancer	0.000244	0.00176	CcSEcCtD
Doxepin—Dizziness—Procarbazine—brain cancer	0.000243	0.00176	CcSEcCtD
Doxepin—Palpitations—Temozolomide—brain cancer	0.000241	0.00174	CcSEcCtD
Doxepin—DRD2—central nervous system—brain cancer	0.000241	0.00243	CbGeAlD
Doxepin—Myalgia—Carmustine—brain cancer	0.00024	0.00173	CcSEcCtD
Doxepin—Chest pain—Carmustine—brain cancer	0.00024	0.00173	CcSEcCtD
Doxepin—ADRA1A—cerebellum—brain cancer	0.00024	0.00242	CbGeAlD
Doxepin—Anxiety—Carmustine—brain cancer	0.000239	0.00173	CcSEcCtD
Doxepin—SLC6A4—brain—brain cancer	0.000238	0.00241	CbGeAlD
Doxepin—Cough—Temozolomide—brain cancer	0.000238	0.00172	CcSEcCtD
Doxepin—CHRM1—brain—brain cancer	0.000237	0.0024	CbGeAlD
Doxepin—KCNH2—central nervous system—brain cancer	0.000237	0.00239	CbGeAlD
Doxepin—Convulsion—Temozolomide—brain cancer	0.000236	0.00171	CcSEcCtD
Doxepin—HTR2B—brain—brain cancer	0.000236	0.00238	CbGeAlD
Doxepin—ADRA2A—midbrain—brain cancer	0.000236	0.00238	CbGeAlD
Doxepin—Hypertension—Temozolomide—brain cancer	0.000235	0.0017	CcSEcCtD
Doxepin—DRD2—cerebellum—brain cancer	0.000235	0.00238	CbGeAlD
Doxepin—Feeling abnormal—Hydroxyurea—brain cancer	0.000235	0.00169	CcSEcCtD
Doxepin—Eye disorder—Etoposide—brain cancer	0.000234	0.00169	CcSEcCtD
Doxepin—Vomiting—Procarbazine—brain cancer	0.000234	0.00169	CcSEcCtD
Doxepin—ADRA2C—central nervous system—brain cancer	0.000234	0.00236	CbGeAlD
Doxepin—HTR2A—gonad—brain cancer	0.000233	0.00235	CbGeAlD
Doxepin—Cardiac disorder—Etoposide—brain cancer	0.000233	0.00168	CcSEcCtD
Doxepin—Flushing—Etoposide—brain cancer	0.000233	0.00168	CcSEcCtD
Doxepin—Confusional state—Carmustine—brain cancer	0.000232	0.00168	CcSEcCtD
Doxepin—Myalgia—Temozolomide—brain cancer	0.000232	0.00168	CcSEcCtD
Doxepin—Arthralgia—Temozolomide—brain cancer	0.000232	0.00168	CcSEcCtD
Doxepin—Rash—Procarbazine—brain cancer	0.000232	0.00168	CcSEcCtD
Doxepin—Dermatitis—Procarbazine—brain cancer	0.000232	0.00167	CcSEcCtD
Doxepin—KCNH2—cerebellum—brain cancer	0.000232	0.00234	CbGeAlD
Doxepin—Anxiety—Temozolomide—brain cancer	0.000231	0.00167	CcSEcCtD
Doxepin—Headache—Procarbazine—brain cancer	0.000231	0.00166	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000231	0.00166	CcSEcCtD
Doxepin—Oedema—Carmustine—brain cancer	0.00023	0.00166	CcSEcCtD
Doxepin—ADRA2A—spinal cord—brain cancer	0.00023	0.00232	CbGeAlD
Doxepin—Discomfort—Temozolomide—brain cancer	0.000229	0.00166	CcSEcCtD
Doxepin—Infection—Carmustine—brain cancer	0.000229	0.00165	CcSEcCtD
Doxepin—ADRA2C—cerebellum—brain cancer	0.000229	0.00231	CbGeAlD
Doxepin—Angiopathy—Etoposide—brain cancer	0.000227	0.00164	CcSEcCtD
Doxepin—HTR2A—pituitary gland—brain cancer	0.000227	0.0023	CbGeAlD
Doxepin—Dry mouth—Temozolomide—brain cancer	0.000227	0.00164	CcSEcCtD
Doxepin—Immune system disorder—Etoposide—brain cancer	0.000226	0.00163	CcSEcCtD
Doxepin—Mediastinal disorder—Etoposide—brain cancer	0.000226	0.00163	CcSEcCtD
Doxepin—Thrombocytopenia—Carmustine—brain cancer	0.000226	0.00163	CcSEcCtD
Doxepin—CYP1A2—endocrine gland—brain cancer	0.000225	0.00228	CbGeAlD
Doxepin—Body temperature increased—Hydroxyurea—brain cancer	0.000225	0.00163	CcSEcCtD
Doxepin—Chills—Etoposide—brain cancer	0.000225	0.00162	CcSEcCtD
Doxepin—Tachycardia—Carmustine—brain cancer	0.000225	0.00162	CcSEcCtD
Doxepin—Confusional state—Temozolomide—brain cancer	0.000224	0.00162	CcSEcCtD
Doxepin—Amitriptyline—CYP2C9—brain cancer	0.000223	0.132	CrCbGaD
Doxepin—Oedema—Temozolomide—brain cancer	0.000223	0.00161	CcSEcCtD
Doxepin—Alopecia—Etoposide—brain cancer	0.000222	0.0016	CcSEcCtD
Doxepin—Infection—Temozolomide—brain cancer	0.000221	0.0016	CcSEcCtD
Doxepin—Anorexia—Carmustine—brain cancer	0.00022	0.00158	CcSEcCtD
Doxepin—HTR2A—medulla oblongata—brain cancer	0.000219	0.00222	CbGeAlD
Doxepin—Nausea—Procarbazine—brain cancer	0.000219	0.00158	CcSEcCtD
Doxepin—Nervous system disorder—Temozolomide—brain cancer	0.000218	0.00158	CcSEcCtD
Doxepin—Thrombocytopenia—Temozolomide—brain cancer	0.000218	0.00157	CcSEcCtD
Doxepin—Skin disorder—Temozolomide—brain cancer	0.000216	0.00156	CcSEcCtD
Doxepin—Hypotension—Carmustine—brain cancer	0.000215	0.00155	CcSEcCtD
Doxepin—Hyperhidrosis—Temozolomide—brain cancer	0.000215	0.00155	CcSEcCtD
Doxepin—CYP2C9—endocrine gland—brain cancer	0.000214	0.00216	CbGeAlD
Doxepin—Dysgeusia—Etoposide—brain cancer	0.000214	0.00154	CcSEcCtD
Doxepin—CHRM3—brain—brain cancer	0.000212	0.00214	CbGeAlD
Doxepin—Anorexia—Temozolomide—brain cancer	0.000212	0.00153	CcSEcCtD
Doxepin—HTR1A—brain—brain cancer	0.000211	0.00214	CbGeAlD
Doxepin—Back pain—Etoposide—brain cancer	0.000211	0.00152	CcSEcCtD
Doxepin—HRH1—endocrine gland—brain cancer	0.000211	0.00213	CbGeAlD
Doxepin—Hypersensitivity—Hydroxyurea—brain cancer	0.00021	0.00152	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00021	0.00151	CcSEcCtD
Doxepin—Muscle spasms—Etoposide—brain cancer	0.00021	0.00151	CcSEcCtD
Doxepin—SLC6A2—brain—brain cancer	0.00021	0.00212	CbGeAlD
Doxepin—Insomnia—Carmustine—brain cancer	0.000208	0.0015	CcSEcCtD
Doxepin—HRH1—head—brain cancer	0.000208	0.0021	CbGeAlD
Doxepin—ADRA2A—endocrine gland—brain cancer	0.000207	0.00209	CbGeAlD
Doxepin—Paraesthesia—Carmustine—brain cancer	0.000207	0.00149	CcSEcCtD
Doxepin—Dyspnoea—Carmustine—brain cancer	0.000205	0.00148	CcSEcCtD
Doxepin—Somnolence—Carmustine—brain cancer	0.000205	0.00148	CcSEcCtD
Doxepin—ADRA2A—head—brain cancer	0.000204	0.00207	CbGeAlD
Doxepin—Asthenia—Hydroxyurea—brain cancer	0.000204	0.00148	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000203	0.00146	CcSEcCtD
Doxepin—Ill-defined disorder—Etoposide—brain cancer	0.000202	0.00146	CcSEcCtD
Doxepin—Anaemia—Etoposide—brain cancer	0.000202	0.00146	CcSEcCtD
Doxepin—Insomnia—Temozolomide—brain cancer	0.000201	0.00145	CcSEcCtD
Doxepin—HTR2A—midbrain—brain cancer	0.0002	0.00203	CbGeAlD
Doxepin—Decreased appetite—Carmustine—brain cancer	0.0002	0.00145	CcSEcCtD
Doxepin—Paraesthesia—Temozolomide—brain cancer	0.0002	0.00144	CcSEcCtD
Doxepin—Gastrointestinal disorder—Carmustine—brain cancer	0.000199	0.00144	CcSEcCtD
Doxepin—Dyspnoea—Temozolomide—brain cancer	0.000198	0.00143	CcSEcCtD
Doxepin—Somnolence—Temozolomide—brain cancer	0.000198	0.00143	CcSEcCtD
Doxepin—Pain—Carmustine—brain cancer	0.000197	0.00142	CcSEcCtD
Doxepin—Constipation—Carmustine—brain cancer	0.000197	0.00142	CcSEcCtD
Doxepin—Malaise—Etoposide—brain cancer	0.000197	0.00142	CcSEcCtD
Doxepin—Vertigo—Etoposide—brain cancer	0.000196	0.00142	CcSEcCtD
Doxepin—Dyspepsia—Temozolomide—brain cancer	0.000196	0.00141	CcSEcCtD
Doxepin—HTR2A—spinal cord—brain cancer	0.000196	0.00198	CbGeAlD
Doxepin—Leukopenia—Etoposide—brain cancer	0.000195	0.00141	CcSEcCtD
Doxepin—Diarrhoea—Hydroxyurea—brain cancer	0.000195	0.00141	CcSEcCtD
Doxepin—ADRA1A—brain—brain cancer	0.000195	0.00197	CbGeAlD
Doxepin—Decreased appetite—Temozolomide—brain cancer	0.000193	0.0014	CcSEcCtD
Doxepin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000192	0.00139	CcSEcCtD
Doxepin—Fatigue—Temozolomide—brain cancer	0.000192	0.00139	CcSEcCtD
Doxepin—Loss of consciousness—Etoposide—brain cancer	0.000192	0.00138	CcSEcCtD
Doxepin—DRD2—brain—brain cancer	0.000191	0.00193	CbGeAlD
Doxepin—Cough—Etoposide—brain cancer	0.00019	0.00137	CcSEcCtD
Doxepin—Constipation—Temozolomide—brain cancer	0.00019	0.00137	CcSEcCtD
Doxepin—Pain—Temozolomide—brain cancer	0.00019	0.00137	CcSEcCtD
Doxepin—HRH1—central nervous system—brain cancer	0.00019	0.00192	CbGeAlD
Doxepin—Feeling abnormal—Carmustine—brain cancer	0.00019	0.00137	CcSEcCtD
Doxepin—Convulsion—Etoposide—brain cancer	0.000189	0.00136	CcSEcCtD
Doxepin—Hypertension—Etoposide—brain cancer	0.000188	0.00136	CcSEcCtD
Doxepin—Dizziness—Hydroxyurea—brain cancer	0.000188	0.00136	CcSEcCtD
Doxepin—Gastrointestinal pain—Carmustine—brain cancer	0.000188	0.00136	CcSEcCtD
Doxepin—KCNH2—brain—brain cancer	0.000188	0.0019	CbGeAlD
Doxepin—ADRA2A—central nervous system—brain cancer	0.000187	0.00189	CbGeAlD
Doxepin—Chest pain—Etoposide—brain cancer	0.000186	0.00134	CcSEcCtD
Doxepin—ADRA2C—brain—brain cancer	0.000186	0.00188	CbGeAlD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000185	0.00133	CcSEcCtD
Doxepin—Discomfort—Etoposide—brain cancer	0.000184	0.00133	CcSEcCtD
Doxepin—Feeling abnormal—Temozolomide—brain cancer	0.000183	0.00132	CcSEcCtD
Doxepin—ABCB1—telencephalon—brain cancer	0.000183	0.00185	CbGeAlD
Doxepin—ADRA2A—cerebellum—brain cancer	0.000182	0.00184	CbGeAlD
Doxepin—Abdominal pain—Carmustine—brain cancer	0.000182	0.00131	CcSEcCtD
Doxepin—Body temperature increased—Carmustine—brain cancer	0.000182	0.00131	CcSEcCtD
Doxepin—Gastrointestinal pain—Temozolomide—brain cancer	0.000182	0.00131	CcSEcCtD
Doxepin—Vomiting—Hydroxyurea—brain cancer	0.000181	0.00131	CcSEcCtD
Doxepin—Rash—Hydroxyurea—brain cancer	0.00018	0.0013	CcSEcCtD
Doxepin—Confusional state—Etoposide—brain cancer	0.00018	0.0013	CcSEcCtD
Doxepin—Dermatitis—Hydroxyurea—brain cancer	0.000179	0.0013	CcSEcCtD
Doxepin—Headache—Hydroxyurea—brain cancer	0.000178	0.00129	CcSEcCtD
Doxepin—Infection—Etoposide—brain cancer	0.000177	0.00128	CcSEcCtD
Doxepin—Urticaria—Temozolomide—brain cancer	0.000177	0.00128	CcSEcCtD
Doxepin—HTR2A—endocrine gland—brain cancer	0.000176	0.00178	CbGeAlD
Doxepin—Abdominal pain—Temozolomide—brain cancer	0.000176	0.00127	CcSEcCtD
Doxepin—Body temperature increased—Temozolomide—brain cancer	0.000176	0.00127	CcSEcCtD
Doxepin—Thrombocytopenia—Etoposide—brain cancer	0.000174	0.00126	CcSEcCtD
Doxepin—HTR2A—head—brain cancer	0.000174	0.00176	CbGeAlD
Doxepin—Tachycardia—Etoposide—brain cancer	0.000174	0.00125	CcSEcCtD
Doxepin—Skin disorder—Etoposide—brain cancer	0.000173	0.00125	CcSEcCtD
Doxepin—Hyperhidrosis—Etoposide—brain cancer	0.000172	0.00124	CcSEcCtD
Doxepin—Anorexia—Etoposide—brain cancer	0.00017	0.00123	CcSEcCtD
Doxepin—Hypersensitivity—Carmustine—brain cancer	0.00017	0.00122	CcSEcCtD
Doxepin—Nausea—Hydroxyurea—brain cancer	0.000169	0.00122	CcSEcCtD
Doxepin—Hypotension—Etoposide—brain cancer	0.000166	0.0012	CcSEcCtD
Doxepin—Asthenia—Carmustine—brain cancer	0.000165	0.00119	CcSEcCtD
Doxepin—Hypersensitivity—Temozolomide—brain cancer	0.000164	0.00118	CcSEcCtD
Doxepin—CYP3A4—endocrine gland—brain cancer	0.000163	0.00165	CbGeAlD
Doxepin—CYP2D6—endocrine gland—brain cancer	0.00016	0.00162	CbGeAlD
Doxepin—Paraesthesia—Etoposide—brain cancer	0.00016	0.00115	CcSEcCtD
Doxepin—Asthenia—Temozolomide—brain cancer	0.00016	0.00115	CcSEcCtD
Doxepin—Dyspnoea—Etoposide—brain cancer	0.000159	0.00115	CcSEcCtD
Doxepin—HTR2A—central nervous system—brain cancer	0.000159	0.0016	CbGeAlD
Doxepin—CYP2D6—head—brain cancer	0.000158	0.0016	CbGeAlD
Doxepin—Somnolence—Etoposide—brain cancer	0.000158	0.00114	CcSEcCtD
Doxepin—Diarrhoea—Carmustine—brain cancer	0.000158	0.00114	CcSEcCtD
Doxepin—Pruritus—Temozolomide—brain cancer	0.000157	0.00114	CcSEcCtD
Doxepin—HTR2A—cerebellum—brain cancer	0.000155	0.00157	CbGeAlD
Doxepin—Decreased appetite—Etoposide—brain cancer	0.000155	0.00112	CcSEcCtD
Doxepin—Gastrointestinal disorder—Etoposide—brain cancer	0.000154	0.00111	CcSEcCtD
Doxepin—Fatigue—Etoposide—brain cancer	0.000154	0.00111	CcSEcCtD
Doxepin—ABCB1—gonad—brain cancer	0.000153	0.00154	CbGeAlD
Doxepin—Dizziness—Carmustine—brain cancer	0.000152	0.0011	CcSEcCtD
Doxepin—Constipation—Etoposide—brain cancer	0.000152	0.0011	CcSEcCtD
Doxepin—Pain—Etoposide—brain cancer	0.000152	0.0011	CcSEcCtD
Doxepin—Diarrhoea—Temozolomide—brain cancer	0.000152	0.0011	CcSEcCtD
Doxepin—HRH1—brain—brain cancer	0.000151	0.00152	CbGeAlD
Doxepin—ABCB1—pituitary gland—brain cancer	0.000149	0.0015	CbGeAlD
Doxepin—ADRA2A—brain—brain cancer	0.000148	0.0015	CbGeAlD
Doxepin—Dizziness—Temozolomide—brain cancer	0.000147	0.00106	CcSEcCtD
Doxepin—CYP3A4—central nervous system—brain cancer	0.000147	0.00148	CbGeAlD
Doxepin—Feeling abnormal—Etoposide—brain cancer	0.000147	0.00106	CcSEcCtD
Doxepin—Vomiting—Carmustine—brain cancer	0.000146	0.00106	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—brain cancer	0.000146	0.00105	CcSEcCtD
Doxepin—Rash—Carmustine—brain cancer	0.000145	0.00105	CcSEcCtD
Doxepin—Dermatitis—Carmustine—brain cancer	0.000145	0.00105	CcSEcCtD
Doxepin—CYP2D6—central nervous system—brain cancer	0.000145	0.00146	CbGeAlD
Doxepin—Headache—Carmustine—brain cancer	0.000144	0.00104	CcSEcCtD
Doxepin—ABCB1—medulla oblongata—brain cancer	0.000144	0.00145	CbGeAlD
Doxepin—Vomiting—Temozolomide—brain cancer	0.000142	0.00102	CcSEcCtD
Doxepin—Urticaria—Etoposide—brain cancer	0.000141	0.00102	CcSEcCtD
Doxepin—CYP2D6—cerebellum—brain cancer	0.000141	0.00143	CbGeAlD
Doxepin—Body temperature increased—Etoposide—brain cancer	0.000141	0.00102	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—brain cancer	0.000141	0.00102	CcSEcCtD
Doxepin—Rash—Temozolomide—brain cancer	0.00014	0.00101	CcSEcCtD
Doxepin—Dermatitis—Temozolomide—brain cancer	0.00014	0.00101	CcSEcCtD
Doxepin—Headache—Temozolomide—brain cancer	0.000139	0.00101	CcSEcCtD
Doxepin—Nausea—Carmustine—brain cancer	0.000137	0.000988	CcSEcCtD
Doxepin—Nausea—Temozolomide—brain cancer	0.000132	0.000954	CcSEcCtD
Doxepin—ABCB1—midbrain—brain cancer	0.000131	0.00133	CbGeAlD
Doxepin—Hypersensitivity—Etoposide—brain cancer	0.000131	0.000947	CcSEcCtD
Doxepin—ABCB1—spinal cord—brain cancer	0.000128	0.00129	CbGeAlD
Doxepin—Asthenia—Etoposide—brain cancer	0.000128	0.000922	CcSEcCtD
Doxepin—Pruritus—Etoposide—brain cancer	0.000126	0.00091	CcSEcCtD
Doxepin—HTR2A—brain—brain cancer	0.000126	0.00127	CbGeAlD
Doxepin—Diarrhoea—Etoposide—brain cancer	0.000122	0.00088	CcSEcCtD
Doxepin—Dizziness—Etoposide—brain cancer	0.000118	0.00085	CcSEcCtD
Doxepin—ABCB1—endocrine gland—brain cancer	0.000115	0.00117	CbGeAlD
Doxepin—CYP2D6—brain—brain cancer	0.000115	0.00116	CbGeAlD
Doxepin—ABCB1—head—brain cancer	0.000114	0.00115	CbGeAlD
Doxepin—Vomiting—Etoposide—brain cancer	0.000113	0.000817	CcSEcCtD
Doxepin—Rash—Etoposide—brain cancer	0.000112	0.000811	CcSEcCtD
Doxepin—Dermatitis—Etoposide—brain cancer	0.000112	0.00081	CcSEcCtD
Doxepin—Headache—Etoposide—brain cancer	0.000112	0.000805	CcSEcCtD
Doxepin—Nausea—Etoposide—brain cancer	0.000106	0.000764	CcSEcCtD
Doxepin—ABCB1—central nervous system—brain cancer	0.000104	0.00105	CbGeAlD
Doxepin—ABCB1—cerebellum—brain cancer	0.000102	0.00103	CbGeAlD
Doxepin—ABCB1—brain—brain cancer	8.26e-05	0.000834	CbGeAlD
Doxepin—ADRA1D—Signaling by GPCR—EGFR—brain cancer	7.02e-06	0.000105	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—STAT3—brain cancer	7e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APC—brain cancer	6.95e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	6.95e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—IL2—brain cancer	6.92e-06	0.000104	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL2—brain cancer	6.91e-06	0.000103	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL2—brain cancer	6.89e-06	0.000103	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—brain cancer	6.89e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CG—brain cancer	6.87e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL2—brain cancer	6.87e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL2—brain cancer	6.85e-06	0.000103	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	6.8e-06	0.000102	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL2—brain cancer	6.78e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL2—brain cancer	6.76e-06	0.000101	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6.71e-06	0.0001	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APC—brain cancer	6.71e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—RELA—brain cancer	6.68e-06	0.0001	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CG—brain cancer	6.68e-06	0.0001	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APC—brain cancer	6.68e-06	0.0001	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IRS2—brain cancer	6.67e-06	9.99e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—ERBB2—brain cancer	6.64e-06	9.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SPP1—brain cancer	6.6e-06	9.89e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IRS2—brain cancer	6.56e-06	9.83e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IRS2—brain cancer	6.55e-06	9.81e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IRS2—brain cancer	6.53e-06	9.78e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IRS2—brain cancer	6.51e-06	9.74e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MYC—brain cancer	6.5e-06	9.74e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	6.49e-06	9.72e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APC—brain cancer	6.49e-06	9.72e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—RELA—brain cancer	6.47e-06	9.68e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IRS2—brain cancer	6.45e-06	9.65e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IRS2—brain cancer	6.43e-06	9.62e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—ERBB2—brain cancer	6.43e-06	9.62e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—RELA—brain cancer	6.4e-06	9.58e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APC—brain cancer	6.39e-06	9.57e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	6.39e-06	9.57e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL2—brain cancer	6.38e-06	9.55e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EGFR—brain cancer	6.36e-06	9.52e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—ERBB2—brain cancer	6.36e-06	9.52e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—EGFR—brain cancer	6.33e-06	9.48e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CG—brain cancer	6.31e-06	9.44e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL2—brain cancer	6.28e-06	9.41e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CCND1—brain cancer	6.22e-06	9.31e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CTNNB1—brain cancer	6.16e-06	9.22e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—EGFR—brain cancer	6.11e-06	9.15e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—EGFR—brain cancer	6.08e-06	9.11e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL2—brain cancer	6.02e-06	9.01e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—RELA—brain cancer	6.02e-06	9.01e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—ERBB2—brain cancer	5.98e-06	8.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IRS2—brain cancer	5.97e-06	8.94e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—EGFR—brain cancer	5.92e-06	8.86e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APC—brain cancer	5.89e-06	8.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CG—brain cancer	5.89e-06	8.82e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCND1—brain cancer	5.87e-06	8.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ENO2—brain cancer	5.86e-06	8.77e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—brain cancer	5.82e-06	8.72e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—EGFR—brain cancer	5.82e-06	8.72e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CTNNB1—brain cancer	5.81e-06	8.7e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APC—brain cancer	5.8e-06	8.68e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CG—brain cancer	5.8e-06	8.68e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.79e-06	8.66e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APC—brain cancer	5.79e-06	8.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APC—brain cancer	5.77e-06	8.63e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CG—brain cancer	5.77e-06	8.63e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—brain cancer	5.76e-06	8.63e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CG—brain cancer	5.75e-06	8.61e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APC—brain cancer	5.75e-06	8.61e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CG—brain cancer	5.69e-06	8.52e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APC—brain cancer	5.69e-06	8.52e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCND1—brain cancer	5.68e-06	8.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	5.68e-06	8.5e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APC—brain cancer	5.68e-06	8.5e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CTNNB1—brain cancer	5.62e-06	8.42e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCND1—brain cancer	5.62e-06	8.41e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CTNNB1—brain cancer	5.56e-06	8.33e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RELA—brain cancer	5.43e-06	8.13e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—brain cancer	5.42e-06	8.12e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—brain cancer	5.42e-06	8.11e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ERBB2—brain cancer	5.4e-06	8.08e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—STAT3—brain cancer	5.37e-06	8.04e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—brain cancer	5.37e-06	8.04e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—brain cancer	5.34e-06	8e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCND1—brain cancer	5.28e-06	7.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—brain cancer	5.28e-06	7.91e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APC—brain cancer	5.27e-06	7.9e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	5.27e-06	7.9e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—brain cancer	5.27e-06	7.89e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—brain cancer	5.25e-06	7.87e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RELA—brain cancer	5.24e-06	7.85e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—brain cancer	5.24e-06	7.84e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	5.23e-06	7.83e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RELA—brain cancer	5.22e-06	7.81e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ERBB2—brain cancer	5.21e-06	7.8e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—brain cancer	5.19e-06	7.76e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ERBB2—brain cancer	5.18e-06	7.76e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—brain cancer	5.17e-06	7.74e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—brain cancer	5.11e-06	7.66e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RELA—brain cancer	5.07e-06	7.6e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—STAT3—brain cancer	5.06e-06	7.58e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ERBB2—brain cancer	5.04e-06	7.55e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RELA—brain cancer	4.99e-06	7.48e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—brain cancer	4.99e-06	7.47e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ERBB2—brain cancer	4.96e-06	7.43e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—brain cancer	4.95e-06	7.41e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—STAT3—brain cancer	4.9e-06	7.34e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—brain cancer	4.9e-06	7.33e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—brain cancer	4.89e-06	7.32e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—brain cancer	4.88e-06	7.31e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—STAT3—brain cancer	4.85e-06	7.26e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—brain cancer	4.81e-06	7.19e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCND1—brain cancer	4.77e-06	7.14e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	4.72e-06	7.07e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—brain cancer	4.72e-06	7.07e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—brain cancer	4.71e-06	7.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—brain cancer	4.7e-06	7.03e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—brain cancer	4.61e-06	6.89e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RELA—brain cancer	4.6e-06	6.89e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCND1—brain cancer	4.6e-06	6.89e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—brain cancer	4.6e-06	6.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—brain cancer	4.58e-06	6.86e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ERBB2—brain cancer	4.58e-06	6.85e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—brain cancer	4.57e-06	6.84e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—brain cancer	4.56e-06	6.83e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.56e-06	6.83e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—brain cancer	4.55e-06	6.82e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CTNNB1—brain cancer	4.54e-06	6.79e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RELA—brain cancer	4.53e-06	6.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RELA—brain cancer	4.52e-06	6.77e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—brain cancer	4.51e-06	6.75e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RELA—brain cancer	4.51e-06	6.75e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.5e-06	6.74e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—brain cancer	4.5e-06	6.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ERBB2—brain cancer	4.49e-06	6.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RELA—brain cancer	4.49e-06	6.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ERBB2—brain cancer	4.48e-06	6.7e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CG—brain cancer	4.47e-06	6.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ERBB2—brain cancer	4.46e-06	6.68e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—brain cancer	4.45e-06	6.67e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—brain cancer	4.45e-06	6.67e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RELA—brain cancer	4.45e-06	6.66e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RELA—brain cancer	4.44e-06	6.64e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.42e-06	6.62e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	4.41e-06	6.6e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—brain cancer	4.41e-06	6.6e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.41e-06	6.6e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.38e-06	6.56e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CG—brain cancer	4.36e-06	6.53e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.34e-06	6.5e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—brain cancer	4.24e-06	6.34e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—brain cancer	4.16e-06	6.22e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—brain cancer	4.15e-06	6.21e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—brain cancer	4.14e-06	6.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RELA—brain cancer	4.12e-06	6.17e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—brain cancer	4.12e-06	6.16e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CG—brain cancer	4.11e-06	6.15e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—brain cancer	4.1e-06	6.13e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB2—brain cancer	4.1e-06	6.13e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—brain cancer	4.08e-06	6.11e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CG—brain cancer	4.07e-06	6.1e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—brain cancer	4.07e-06	6.09e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—brain cancer	4.06e-06	6.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—brain cancer	4.05e-06	6.06e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—brain cancer	4.04e-06	6.05e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—brain cancer	4.01e-06	6.01e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—brain cancer	4.01e-06	6e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CTNNB1—brain cancer	4e-06	5.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—brain cancer	3.99e-06	5.98e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—brain cancer	3.99e-06	5.98e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—brain cancer	3.98e-06	5.95e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—brain cancer	3.97e-06	5.95e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—brain cancer	3.97e-06	5.94e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—brain cancer	3.96e-06	5.92e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—brain cancer	3.95e-06	5.92e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—brain cancer	3.94e-06	5.9e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.94e-06	5.9e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.93e-06	5.88e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—brain cancer	3.92e-06	5.86e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—brain cancer	3.91e-06	5.85e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—brain cancer	3.91e-06	5.85e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.89e-06	5.83e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—brain cancer	3.88e-06	5.81e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.87e-06	5.79e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—brain cancer	3.86e-06	5.79e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.86e-06	5.77e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—brain cancer	3.85e-06	5.76e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—brain cancer	3.83e-06	5.73e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—brain cancer	3.82e-06	5.72e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—brain cancer	3.78e-06	5.67e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—brain cancer	3.74e-06	5.6e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—brain cancer	3.74e-06	5.6e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—brain cancer	3.71e-06	5.56e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—brain cancer	3.7e-06	5.54e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—brain cancer	3.69e-06	5.53e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—brain cancer	3.67e-06	5.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—brain cancer	3.62e-06	5.42e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—brain cancer	3.61e-06	5.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—brain cancer	3.59e-06	5.38e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.58e-06	5.36e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—brain cancer	3.57e-06	5.35e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—brain cancer	3.52e-06	5.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—brain cancer	3.52e-06	5.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—brain cancer	3.5e-06	5.23e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—brain cancer	3.49e-06	5.22e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—brain cancer	3.48e-06	5.21e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—brain cancer	3.48e-06	5.21e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.47e-06	5.19e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—brain cancer	3.46e-06	5.18e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.45e-06	5.16e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.44e-06	5.15e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—brain cancer	3.44e-06	5.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—brain cancer	3.43e-06	5.14e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—brain cancer	3.43e-06	5.13e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—brain cancer	3.41e-06	5.11e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.4e-06	5.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—brain cancer	3.4e-06	5.1e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.4e-06	5.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—brain cancer	3.37e-06	5.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.36e-06	5.03e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—brain cancer	3.24e-06	4.85e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—brain cancer	3.19e-06	4.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—brain cancer	3.18e-06	4.77e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—brain cancer	3.17e-06	4.75e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—brain cancer	3.17e-06	4.75e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—brain cancer	3.16e-06	4.74e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.15e-06	4.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—brain cancer	3.14e-06	4.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—brain cancer	3.13e-06	4.69e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—brain cancer	3.12e-06	4.68e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.12e-06	4.68e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—brain cancer	3.12e-06	4.67e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—brain cancer	3.11e-06	4.66e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—brain cancer	3.1e-06	4.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—brain cancer	3.09e-06	4.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—brain cancer	3.06e-06	4.59e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.06e-06	4.57e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—brain cancer	3.03e-06	4.54e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—brain cancer	3.02e-06	4.52e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—brain cancer	2.93e-06	4.39e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—brain cancer	2.9e-06	4.35e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—brain cancer	2.89e-06	4.32e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—brain cancer	2.84e-06	4.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.69e-06	4.02e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—brain cancer	2.66e-06	3.99e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—brain cancer	2.62e-06	3.92e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—brain cancer	2.61e-06	3.91e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—brain cancer	2.61e-06	3.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—brain cancer	2.6e-06	3.89e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—brain cancer	2.57e-06	3.85e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—brain cancer	2.57e-06	3.84e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—brain cancer	2.38e-06	3.57e-05	CbGpPWpGaD
